Legal Status
Legal Status
Notice
Manufacturer of Controlled Substances; Notice of Registration
A Notice by the Drug Enforcement Administration on
Document Details
Information about this document as published in the Federal Register.
- Printed version:
- Publication Date:
- 12/04/2007
- Agencies:
- Drug Enforcement Administration
- Document Type:
- Notice
- Document Citation:
- 72 FR 68193
- Page:
- 68193-68195 (3 pages)
- Document Number:
- E7-23508
Document Details
-
Enhanced Content - Table of Contents
This tables of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no substantive legal effect.
There is no table of contents available for this document.Enhanced Content - Table of Contents
-
Enhanced Content - Submit Public Comment
- This feature is not available for this document.
Enhanced Content - Submit Public Comment
-
Enhanced Content - Read Public Comments
- This feature is not available for this document.
Enhanced Content - Read Public Comments
-
Enhanced Content - Sharing
- Shorter Document URL
- https://www.federalregister.gov/d/E7-23508 https://www.federalregister.gov/d/E7-23508
Enhanced Content - Sharing
-
Enhanced Content - Document Tools
These tools are designed to help you understand the official document better and aid in comparing the online edition to the print edition.
-
These markup elements allow the user to see how the document follows the Document Drafting Handbook that agencies use to create their documents. These can be useful for better understanding how a document is structured but are not part of the published document itself.
Display Non-Printed Markup Elements
Enhanced Content - Document Tools
-
-
Enhanced Content - Developer Tools
This document is available in the following developer friendly formats:
- JSON: Normalized attributes and metadata
- XML: Original full text XML
- MODS: Government Publishing Office metadata
More information and documentation can be found in our developer tools pages.
Enhanced Content - Developer Tools
Published Document
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
By Notice dated August 16, 2007, and published in the Federal Register on August 28, 2007, (72 FR 49315-49316), Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78664, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Start Printed Page 68194
Drug | Schedule |
---|---|
Cathinone (1235) | I |
Methcathinone (1237) | I |
N-Ethylamphetamine (1475) | I |
N,N-Dimethylamphetamine (1480) | I |
Aminorex (1585) | I |
4-Methylaminorex (cis isomer) (1590) | I |
Gamma-Hydroxybutyric acid (2010) | I |
Methaqualone (2565) | I |
Alpha-Ethyltryptamine (7249) | I |
Lysergic acid diethylamide (7315) | I |
Marihuana (7360) | I |
Tetrahydrocannabinols (7370) | I |
Mescaline (7381) | I |
3,4,5-Trimethoxyamphetamine (7390) | I |
4-Bromo-2,5-dimethoxyamphetamine (7391) | I |
4-Bromo-2,5-dimethoxyphenethylamine (7392) | I |
4-Methyl-2,5-dimethoxyamphetamine (7395) | I |
2,5-Dimethoxyamphetamine (7396) | I |
2,5-Dimethoxy-4-ethylamphetamine (7399) | I |
3,4-Methylenedioxyamphetamine (7400) | I |
5-Methoxy-3,4-methylenedioxyamphetamine (7401) | I |
N-Hydroxy-3,4-methylendioxyamphetamine (7402) | I |
3,4-Methylendioxy-N-ethylamphetamine (7404) | I |
3,4-Methylenedioxymethamphetamine (7405) | I |
4-Methoxyamphetamine (7411) | I |
Alpha-methyltryptamine (7432) | I |
Bufotenine (7433) | I |
Diethyltryptamine (7434) | I |
Dimethyltryptamine (7435) | I |
Psilocybin (7437) | I |
Psilocyn (7438) | I |
Acetyldihydrocodeine (9051) | I |
Benzylmorphine (9052) | I |
Codeine-N-oxide (9053) | I |
Dihydromorphine (9145) | I |
Heroin (9200) | I |
Hydromorphinol (9301) | I |
Methyldihydromorphine (9304) | I |
Morphine-N-oxide (9307) | I |
Normorphine (9313) | I |
Pholcodine (9314) | I |
Acetylmethadol (9601) | I |
Allylprodine (9602) | I |
Alphacetylmethadol except levo-alphacetylmethadol (9603) | I |
Alphameprodine (9604) | I |
Alphamethadol (9605) | I |
Betacetylmethadol (9607) | I |
Betameprodine (9608) | I |
Betamethadol (9609) | I |
Betaprodine (9611) | I |
Hydroxypethidine (9627) | I |
Noracymethadol (9633) | I |
Norlevorphanol (9634) | I |
Normethadone (9635) | I |
Trimeperidine (9646) | I |
Phenomorphan (9647) | I |
Para-Fluorofentanyl (9812) | I |
3-Methylfentanyl (9813) | I |
Alpha-Methylfentanyl (9814) | I |
Acetyl-alpha-methylfentanyl (9815) | I |
Beta-hydroxyfentanyl (9830) | I |
Beta-hydroxy-3-methylfentanyl (9831) | I |
Alpha-Methylthiofentanyl (9832) | I |
3-Methylthiofentanyl (9833) | I |
Thiofentanyl (9835) | I |
Amphetamine (1100) | II |
Methamphetamine (1105) | II |
Phenmetrazine (1631) | II |
Methylphenidate (1724) | II |
Ambobarbital (2125) | II |
Pentobarbital (2270) | II |
Secobarbital (2315) | II |
Glutethimide (2550) | II |
Nabilone (7379) | II |
Start Printed Page 68195 | |
1-Phenylcyclohexylamine (7460) | II |
Phencyclidine (7471) | II |
1-Piperidinocyclohexanecarbonitrile (8603) | II |
Alphaprodine (9010) | II |
Cocaine (9041) | II |
Codeine (9050) | II |
Dihydrocodeine (9120) | II |
Oxycodone (9143) | II |
Hydromorphone (9150) | II |
Diphenoxylate (9170) | II |
Benzoylecgonine (9180) | II |
Ethylmorphine (9190) | II |
Hydrocodone (9193) | II |
Levomethorphan (9210) | II |
Levorphanol (9220) | II |
Isomethadone (9226) | II |
Meperidine (9230) | II |
Methadone (9250) | II |
Methadone intermediate (9254) | II |
Dextropropoxyphene, bulk (non-dosage forms) (9273) | II |
Morphine (9300) | II |
Thebaine (9333) | II |
Levo-alphacetylmethadol (9648) | II |
Oxymorphone (9652) | II |
Noroxymorphone (9668) | II |
Racemethorphan (9732) | II |
Alfentanil (9737) | II |
Sufentanil (9740) | II |
Fentanyl (9801) | II |
The company plans to manufacture small quantities of the listed controlled substances to make reference standards which will be distributed to their customers.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cerilliant Corporation to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.
Start SignatureDated: November 26, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E7-23508 Filed 12-3-07; 8:45 am]
BILLING CODE 4410-09-P